Genprex Inc (GNPX) recently have taken one step ahead with the beta value of -0.58

As on Wednesday, Genprex Inc (NASDAQ: GNPX) started slowly as it slid -17.21% to $2.02, before settling in for the price of $2.44 at the close. Taking a more long-term approach, GNPX posted a 52-week range of $0.28-$14.80.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 8.89%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 75.40%. This publicly-traded company’s shares outstanding now amounts to $2.59 million, simultaneously with a float of $2.43 million. The organization now has a market capitalization sitting at $5.23 million. At the time of writing, stock’s 50-day Moving Average stood at $0.76, while the 200-day Moving Average is $2.61.

Genprex Inc (GNPX) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Genprex Inc’s current insider ownership accounts for 6.26%, in contrast to 10.48% institutional ownership.

Genprex Inc (GNPX) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.

Genprex Inc’s EPS increase for this current 12-month fiscal period is 75.40% and is forecasted to reach -1.65 in the upcoming year.

Genprex Inc (NASDAQ: GNPX) Trading Performance Indicators

Let’s observe the current performance indicators for Genprex Inc (GNPX). It’s Quick Ratio in the last reported quarter now stands at 1.95. The Stock has managed to achieve an average true range (ATR) of 0.46.

In the same vein, GNPX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -16.05, a figure that is expected to reach -2.73 in the next quarter, and analysts are predicting that it will be -1.65 at the market close of one year from today.

Technical Analysis of Genprex Inc (GNPX)

Through scrutinizing the latest numbers posted by the [Genprex Inc, GNPX], it can be observed that its last 5-days Average volume of 7.13 million was better the volume of 2.77 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 57.04% While, its Average True Range was 0.57.

Raw Stochastic average of Genprex Inc (GNPX) in the period of the previous 100 days is set at 47.15%, which indicates a major rise in contrast to 46.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 671.54% that was higher than 283.25% volatility it exhibited in the past 100-days period.